Cargando…
Longitudinal analysis of premotor anthropometric and serological markers of Parkinson’s disease
Parkinson’s disease (PD) is a debilitating neurodegenerative disorder in which nonmotor symptoms, such as constipation and hyposmia, precede the onset of motor symptoms by 20 years. The aim of this study was to identify biomarkers at the premotor stage of PD. We assessed the differences in longitudi...
Autores principales: | Yokoi, Katsunori, Hattori, Makoto, Satake, Yuki, Tanaka, Yasuhiro, Sato, Maki, Hashizume, Atsushi, Hori, Akihiro, Kawashima, Motoshi, Hirakawa, Akihiro, Watanabe, Hirohisa, Katsuno, Masahisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7688961/ https://www.ncbi.nlm.nih.gov/pubmed/33239649 http://dx.doi.org/10.1038/s41598-020-77415-1 |
Ejemplares similares
-
Clinico-imaging features of subjects at risk of Lewy body disease in NaT-PROBE baseline analysis
por: Hattori, Makoto, et al.
Publicado: (2023) -
Effects of MAO-B inhibitors on non-motor symptoms and quality of life in Parkinson’s disease: A systematic review
por: Tsuboi, Takashi, et al.
Publicado: (2022) -
Development of a functional composite for the evaluation of spinal and bulbar muscular atrophy
por: Inagaki, Tomonori, et al.
Publicado: (2022) -
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)
por: Yamada, Shinichiro, et al.
Publicado: (2018) -
Mexiletine in spinal and bulbar muscular atrophy: a randomized controlled trial
por: Yamada, Shinichiro, et al.
Publicado: (2022)